Lung cancer in older patients

Инновационная медицина Кубани

S. P. Pyltsin¹  O. N. Stateshny²  E. A. Mirzoyan²  I. A. Leyman²  Yu. N. Lazutin²  D. A. Kharagezov²  A. G. Milakin² 

[1] Городская поликлиника № 14;Национальный медицинский исследовательский центр;

关键词: рак легкого;    пожилые больные;    скрининг;    гериатрическая оценка;    хирургическое лечение;    стереотаксическая лучевая терапия;    таргетная терапия;    иммунотерапия;   

DOI  :  10.35401/2500-0268-2021-22-2-65-71

来源: DOAJ

【 摘 要 】

Increasing life expectancy is the goal of social programs in the Russian Federation as a reflection of the success of public health. Globally, there is a trend for aging of the population, contributing to an increased risk for lung cancer developing which is primarily a disease of the elderly. Chronologic age or performance scores alone are not accurate predictors of patients’ capacity for tolerating aggressive cancer therapies. Use of a comprehensive geriatric assessment to determine treatment strategy is able to reduce toxicities and treatment failures. Safe elderly patients are often able to tolerate surgical resection, radiation, and/or chemotherapy appropriate for their tumor stage, with outcomes similar to those of younger patients, albeit with higher rates of treatment-related toxicity.

【 授权许可】

Unknown